<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503797/bin/JOMFP-23-159-g005.jpg"/> </div> <div class="text-side"> <h1>An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.</h1> <p>Progressive decrease in podoplanin expression in varying grades of oral squamous cell carcinoma. (a) Well differentiated, (b) moderately differentiated, (c) poorly differentiated ([a-c], H&amp;E, ×40), (d) Intense expression and staining in tumor islands in well-differentiated group where both central and peripheral cells of the islands show strong expression, (e) Less intense expression and restricted to peripheral cells in moderately differentiated group, (f) Least expression and weak staining of tumor cells in poorly differentiated group, ([d-f], immunohistochemistry podoplanin, ×40)</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31110440/" target="_blank">31110440</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>